Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) Rose 1.87% to 152.200
Newtimespace News, as of 11:56 on May 14, Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) was quoted at HKD 152.200, up 1.87%. The ETF opened at HKD 162.000, with a high of HKD 162.000 and a low of HKD 151.700. The latest NAV per unit is HKD 145.633, with a premium rate of 2.59%. The asset size is approximately HKD 16.241 billion.
Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) is a leveraged product issued by CSOP Asset Management Limited. It aims to provide investment returns that correspond to twice (2x) the daily performance of the ordinary shares of Samsung Electronics Co., Ltd. The underlying asset is Samsung Electronics, a global leader in the semiconductor industry. The company focuses on core sectors such as memory chips, smartphones, and consumer electronics, making it a key participant in the global technology industry supply chain.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HATCHER GROUP (08365.HK): Shareholder Buys Back 36% Stake in Target Company for HKD 1, Cutting Group's Stake to 15%; Target Signs Strategic Investment LOI for Low-Altitude Economy Project
- C HEALTH GP (08225.HK): Provides Update on Receivables Recovery; Applies to Set Aside Rejected Arbitration Award against Related Party, Collects RMB 2.088 Million from Cooperative Customers since June
- VGT (02476.HK): Third-Level Wholly-Owned Subsidiaries Sign Maximum Guarantee Agreements, Providing Mutual Guarantees of RMB 30 Million within Annual Guarantee Limit
- VIVA GOODS (00933.HK): Acquires Further 17,253,500 Li Ning Shares on Open Market for about HKD 228,207,000; Stake to Rise to about 17.58%
- OCUMENSION-B (01477.HK): Phase III Trial of Dry Eye Drug OT-211 Completes Enrollment of 398 Patients in China